Deactivation of the NLRP3 inflammasome is accompanied by improved glucose homeostasis in obese T2DM patients who lose excess weight through dietary intervention, suggesting that inflammasome may be a clinically significant mechanism linking inflammation with T2DM [26]. Here, NLRP3 is linked to type 2 diabetes mellitus.